They include 750m from AstraZeneca and 550m from Covaxin

Also In This Package
Oxygen aid arrives in India as death toll hits new high
Photos: India’s COVID-19 cases cross 20 million
COVID -19: India’s vaccine programme needs a boost
COVID-19: Indian states under lockdown or similar curbs
Subdued poll celebrations amid COVID-19 surge in India
India elections 2021: How movie stars are faring
Mumbai: More than 2 billion doses of coronavirus vaccines will likely be available in India between August to December this year, a top government advisor said on Thursday.
Those doses would include 750 million of AstraZeneca’s vaccine, produced in India by the Serum Institute of India, as well as 550 million doses of Covaxin, made by Bharat Biotech, government advisor V.K. Paul told reporters at a news conference on Thursday.
Several Indian states are reporting an acute shortage of vaccines, even as coronavirus cases surge across the country.
Sign up for the Daily Briefing
Get the latest news and updates straight to your inbox
Network Links
GN StoreDownload our app
© Al Nisr Publishing LLC 2026. All rights reserved.